# Investigation of Efficacy and Safety of Electrical Signal Therapy Provided by Dr Biolyse® Device in COVID-19 Disease

> **NCT06113757** · NA · COMPLETED · sponsor: **AVB Biotechnology** · enrollment: 100 (actual)

## Conditions studied

- COVID-19 Pneumonia
- Virus Diseases
- COVID-19

## Interventions

- **DEVICE:** Signal Therapy provided by Dr.Biolyse device
- **OTHER:** Liquid Support Treatment

## Key facts

- **NCT ID:** NCT06113757
- **Lead sponsor:** AVB Biotechnology
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-09-01
- **Primary completion:** 2023-05-16
- **Final completion:** 2024-04-15
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2024-07-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06113757

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06113757, "Investigation of Efficacy and Safety of Electrical Signal Therapy Provided by Dr Biolyse® Device in COVID-19 Disease". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT06113757. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*